CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 337 enrolled
Drug / intervention
intravenous crystalloid fluid, 500 mLdrug
Likely dose
intravenous crystalloid fluid, 500 mLAI-extracted
Key inclusion· 4
  • Age ≥18 years
  • Admitted to participating study unit
  • Planned endotracheal intubation by a provider who routinely performs this procedure at the study site
  • Sedation with or without neuromuscular blockade planned
Key exclusion· 5
  • Operator believes fluid loading absolutely indicated or contraindicated for safe patient care
  • Intubation urgency precludes safe performance of study procedures
  • Pregnancy
  • Prisoners

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03026777
NCT03026777Phase 4Completed

Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial

Louisiana State University Health Sciences Center in New Orleans·interventional·Posted Jan 20, 2017·Updated Jan 5, 2021

In Brief

A Phase 4 clinical trial evaluating intravenous crystalloid fluid, 500 mL for Acute Respiratory Failure and Intubation Complication. Completed, enrolled 337 participants across 7 sites.

Detailed Summary

Endotracheal intubation is common in the care of critically ill patients. Complications of airway management in this setting are frequently encountered and may be associated with an increased risk of death. The prevention of complications during urgent and emergent endotracheal intubation is a key focus for airway management research. Post-intubation hypotension (PIH), a common complication of endotracheal intubation in the critically ill, may be prevented by a bolus of intravenous fluid prior to the start of the procedure, but this approach has not been examined in a prospective trial. There are no randomized trials of intravenous fluid administration to prevent PIH in critically ill adults. The investigators propose a randomized trial of fluid loading to prevent PIH in critically ill adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 20, 2017
Enrollment StartJan 1, 2017
Primary CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 9.5 years ago

Interventions

intravenous crystalloid fluid, 500 mLdrug